We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+11.25%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$69M
Cap. Flow
+$46.5M
Cap. Flow %
14.94%
Top 10 Hldgs %
34.58%
Holding
105
New
32
Increased
29
Reduced
26
Closed
17

Top Buys

Rank Stock Value
1
UHS icon
Universal Health Services
UHS
+$11.2M
2
OXFD
Oxford Immunotec Global PLC Ordinary Shares
OXFD
+$7.93M
3
VWR
VWR Corporation
VWR
+$6.84M
4
CTLT
CATALENT, INC.
CTLT
+$6.5M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$5.82M

Top Sells

Rank Stock Value
1
STJ
St Jude Medical
STJ
+$9.69M
2
EHC icon
Encompass Health
EHC
+$5.34M
3
SHPG
Shire pic
SHPG
+$4.9M
4
MCK icon
McKesson
MCK
+$4.57M
5
HOLX
Hologic
HOLX
+$3.28M

Sector Composition

Rank Sector Weight
1 Healthcare 86.32%
2 Financials 3.19%
3 Industrials 2.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVRO
51
DELISTED
NEVRO CORP.
NVRO
$1.69M 0.54%
18,020
+8,600
+91% +$779K
FOLD
52
DELISTED
Amicus Therapeutics
FOLD
$1.59M 0.51%
223,300
-2,000
-0.9% -$12.6K
AERI
53
DELISTED
Aerie Pharmaceuticals
AERI
$1.51M 0.49%
33,330
-29,300
-47% -$1.31M
GILD icon
54
Gilead Sciences
GILD
$162B
$1.49M 0.48%
+22,000
New +$1.55M
LLY icon
55
Eli Lilly
LLY
$1.02T
$1.49M 0.48%
17,700
-20,400
-54% -$1.63M
LUMO
56
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.43M 0.46%
+6,605
New +$943K
VREX icon
57
Varex Imaging
VREX
$472M
$1.43M 0.46%
+42,500
New +$1.34M
XENE icon
58
Xenon Pharmaceuticals
XENE
$6.06B
$1.36M 0.44%
+340,672
New +$2.68M
DPLO
59
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$1.36M 0.44%
+85,043
New +$1.23M
JNJ icon
60
Johnson & Johnson
JNJ
$618B
$1.26M 0.4%
10,100
+1,700
+20% +$203K
CNMD icon
61
CONMED
CNMD
$1.39B
$1.2M 0.39%
+27,100
New +$1.17M
ZSAN
62
DELISTED
Zosano Pharma Corporation
ZSAN
$1.14M 0.36%
+853
New +$1.03M
PBYI icon
63
Puma Biotechnology
PBYI
$404M
$1.1M 0.35%
+29,600
New +$1.08M
DERM
64
DELISTED
Dermira, Inc.
DERM
$1.06M 0.34%
31,188
+6,100
+24% +$197K
DVAX
65
DELISTED
Dynavax Technologies
DVAX
$1.03M 0.33%
173,458
+116,658
+205% +$561K
PDCO
66
DELISTED
Patterson Companies, Inc.
PDCO
$1.01M 0.33%
+22,400
New +$972K
TVTY
67
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$928K 0.3%
+31,900
New +$842K
KERX
68
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$875K 0.28%
+142,100
New +$779K
PRTA icon
69
Prothena Corp
PRTA
$425M
$815K 0.26%
+14,600
New +$767K
ARA
70
DELISTED
American Renal Associates Holdings, Inc
ARA
$776K 0.25%
+45,978
New +$917K
ALDR
71
DELISTED
Alder Biopharmaceuticals
ALDR
$763K 0.25%
+36,700
New +$812K
HUM icon
72
Humana
HUM
$43.7B
$742K 0.24%
+3,600
New +$744K
ZBH icon
73
Zimmer Biomet
ZBH
$18.2B
$716K 0.23%
6,040
-15,965
-73% -$1.81M
RVTY icon
74
Revvity
RVTY
$12.6B
$673K 0.22%
+11,593
New +$632K
SYNH
75
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$514K 0.17%
+11,200
New +$557K
1 2
3
4 5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Endurant Capital Management held 105 positions worth $311M, up 29% from $242M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Endurant Capital Management deployed $46.5M of net new capital in Q1 2017, opening 32 new positions and adding to 29 existing holdings. Its largest new stake was Universal Health Services: 95,100 shares worth $11.8M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 88% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Encompass Health, an estimated $5.34M trimmed.

  • Endurant Capital Management's largest Q1 2017 buy was Universal Health Services: 95,100 shares worth $11.8M.
  • Endurant Capital Management added most to Oxford Immunotec Global PLC Ordinary Shares in Q1 2017, an estimated $7.93M increase.
  • Endurant Capital Management's biggest Q1 2017 reduction was Encompass Health, cutting an estimated $5.34M.
  • Endurant Capital Management fully exited St Jude Medical in Q1 2017, selling an estimated $9.69M.
  • Endurant Capital Management's ten largest holdings make up 35% of its $311M portfolio in Q1 2017.
  • Endurant Capital Management opened 32 new positions and closed 17 in Q1 2017.
  • Endurant Capital Management's portfolio value rose 29% quarter-over-quarter to $311M.

Based on Endurant Capital Management's 13F filing for Q1 2017, filed 15 May 2017.